CP and cancer: In several cancer cell types with high gasdermin E (GSDME) expression, CP treatment also led to pyroptosis [142], a highly inflammatory manifestation of programmed necrosis caused by gasdermin (including GSDME) cleavage by caspase 3, leading to GSDMN pore formation that perforates the cell membrane [218,219,220,221].